Optometry 360
  • Home
  • Conferences
  • Videos
  • About Us
    • About Us – Mission
    • Media Partners
    • Advisory Board
    • Industry Council
    • Business Team

What are you looking for?

  • Conference Roundup
  • Contact Lenses
  • Diagnostics
  • Glaucoma
  • Myopia
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Retina
  • Spotlight Series
The evolving role of the optometrist in nonsurgical cataract management
Optometry 360
  • Home
  • Conferences
  • Videos
  • About Us
    • About Us – Mission
    • Media Partners
    • Advisory Board
    • Industry Council
    • Business Team
Home > Topical ocular lubricants significantly reduce corneal epithelial thickness irregularity in dry eye
  • Ocular Surface Disease

Topical ocular lubricants significantly reduce corneal epithelial thickness irregularity in dry eye

Kelsey Moroz

Regular use of topical ocular lubricants significantly reduces corneal epithelial thickness irregularity in dry eye sufferers within just 48 hours, with improvements sustained for up to 4 weeks, according to a study.

This prospective, single-center, investigator-masked, randomized, parallel-group study involved 48 participants with moderate to severe dry eye symptoms, evidenced by an Ocular Surface Disease Index (OSDI) score greater than 23 at baseline. Participants were randomly assigned to receive one of the following treatments: 0.15% hyaluronic acid + hydroxypropyl guar, 0.2% hyaluronic acid, or saline, with 16 participants in each group. Corneal epithelial thickness was measured at baseline, 48 hours, 2 weeks, and 4 weeks. The OSDI questionnaire was administered at baseline, 2 weeks, and 4 weeks.

Overall, horizontal epithelial thickness irregularity factor showed a significant reduction at all follow-up visits compared to baseline (P = 0.001). However, there were no significant differences between the different eye drops (P = 0.34). Vertical epithelial thickness irregularity factor did not show significant changes over time (P = 0.32) or between different treatments (P = 0.08). Notably, ocular symptoms significantly improved after 2 and 4 weeks of treatment compared to baseline (P < 0.001), though no differences were observed between the various eye drops (P = 0.46).

Reference
Tan J, Chidi-Egboka N, Jia T, et al. Changes in corneal epithelial irregularity following treatment with artificial tears. Optom Vis Sci. 2024;doi: 10.1097/OPX.0000000000002136. Epub ahead of print. PMID: 38775789.

Share

Related Content

  • Ocular Surface Disease

Perceived stress may precede worsening dry eye symptoms in young adults

  • Ocular Surface Disease

Post-menopausal women show more severe evaporative dry eye disease

  • Ocular Surface Disease

Dry eye diagnostic practices remain inconsistent worldwide, survey finds

  • Ocular Surface Disease

Spotlight on VEVYE®

  • Ocular Surface Disease

Intervening early in dry eye disease: reducing patient cost and disease burden

  • Ocular Surface Disease

Consensus guidance helps identify misdiagnosed demodex blepharitis

Share

Advisory Board

Kaleb Abbott, OD, MS, FAAO

Clark Chang, OD

Jessica Haynes, OD, FAAO, FORS, Dipl ABO

Monica Kalia, OD

Cecelia Koetting, OD, FAAO, DipABO

Roya Attar, OD, MBA, DHA, FAAO

Hardeep Kataria, OD, FAAO

Marc R. Bloomenstein, OD, FAAO

Elise Kramer, OD

See All
Optometry 360

Optometry 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

© 2026 Optometry 360 is a trademark of International Healthcare Media, LLC. All rights Reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophthalmology360 Icon